1. Home
  2. MRNA vs CUBE Comparison

MRNA vs CUBE Comparison

Compare MRNA & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • CUBE
  • Stock Information
  • Founded
  • MRNA 2010
  • CUBE 2004
  • Country
  • MRNA United States
  • CUBE United States
  • Employees
  • MRNA 5800
  • CUBE N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • CUBE Real Estate Investment Trusts
  • Sector
  • MRNA Health Care
  • CUBE Real Estate
  • Exchange
  • MRNA Nasdaq
  • CUBE Nasdaq
  • Market Cap
  • MRNA 10.3B
  • CUBE 9.9B
  • IPO Year
  • MRNA 2018
  • CUBE 2004
  • Fundamental
  • Price
  • MRNA $25.90
  • CUBE $42.37
  • Analyst Decision
  • MRNA Hold
  • CUBE Buy
  • Analyst Count
  • MRNA 19
  • CUBE 14
  • Target Price
  • MRNA $48.13
  • CUBE $48.57
  • AVG Volume (30 Days)
  • MRNA 10.5M
  • CUBE 1.6M
  • Earning Date
  • MRNA 07-31-2025
  • CUBE 07-31-2025
  • Dividend Yield
  • MRNA N/A
  • CUBE 4.90%
  • EPS Growth
  • MRNA N/A
  • CUBE N/A
  • EPS
  • MRNA N/A
  • CUBE 1.69
  • Revenue
  • MRNA $3,177,000,000.00
  • CUBE $1,079,894,000.00
  • Revenue This Year
  • MRNA N/A
  • CUBE $2.55
  • Revenue Next Year
  • MRNA $9.87
  • CUBE $3.65
  • P/E Ratio
  • MRNA N/A
  • CUBE $25.12
  • Revenue Growth
  • MRNA N/A
  • CUBE 1.89
  • 52 Week Low
  • MRNA $23.15
  • CUBE $34.24
  • 52 Week High
  • MRNA $138.07
  • CUBE $55.14
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 46.10
  • CUBE 47.52
  • Support Level
  • MRNA $25.06
  • CUBE $42.70
  • Resistance Level
  • MRNA $28.72
  • CUBE $43.52
  • Average True Range (ATR)
  • MRNA 1.18
  • CUBE 0.70
  • MACD
  • MRNA -0.18
  • CUBE -0.12
  • Stochastic Oscillator
  • MRNA 20.34
  • CUBE 8.07

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: